Moderna failed to meet FDA’s requirements for COVID-19 booster vaccines
Category: #headlines  | By Nikita Chaurasia  | Date: 2021-10-15 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Moderna failed to meet FDA’s requirements for COVID-19 booster vaccines

Scientists from the U.S. Food and Drug Administration (FDA) claimed that Moderna did not meet all the requirements to support the use of COVID-19 booster shots. This is because the first two shots already showed a strong efficacy rate.

Documents released by the FDA stated that although Moderna’s vaccine increased the protective antibodies, the difference in antibody levels prior to as well as after the shot was not broad enough, especially in those who already had strong antibody levels.

While the FDA usually follows the advice of its experts, it is not required to do so. Moreover, if the FDA authorizes the booster, a panel from the U.S. Centers for Disease Control and Prevention will meet to further discuss specific recommendations on who can receive the booster shots.

Moderna has applied for authorization for a 50-microgram booster dose, which is half the strength of the original vaccine that is given in two shots. The American biopharmaceutical giant has urged regulators to approve the third round of shots for high-risk individuals and adults aged 65 and above.

It is worth noting here that the Biden administration had announced plans to introduce booster shots for adults. However, some FDA scientists claimed that there was not enough evidence to offer boosters for all.

Data on the need for boosters have predominately come from Israel, which rolled out additional shots of the Pfizer/BioNTech vaccine to the population. The country has also provided details on the effectiveness of the boosters to U.S. advisers.

On the contrary, no similar study has been conducted for the Johnson & Johnson (J&J) as well as Moderna vaccines. Speaking of which, FDA advisors are planning to consider booster shots for Johnson & Johnson’s single-dose vaccine.

Even J&J had asked the U.S. regulator to authorize a booster two months after the initial dose. The company believes that high-risk adults should receive booster shots earlier, while the lower-risk individuals could benefit from waiting for around six months for their second vaccine.

Source Credits –

https://health.economictimes.indiatimes.com/news/pharma/u-s-fda-staff-says-moderna-did-not-meet-all-criteria-for-covid-19-boosters/86990545

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

PM Liz Truss to launch comprehensive review of UK’s visa policy

PM Liz Truss to launch comprehensive review of UK’s visa policy

By Nikita Chaurasia

Newly appointed Prime Minister Liz Truss is considering doing a complete review of Britain's visa system, as the nation struggles with severe labor shortages in vital industries. Business leaders across the UK have reportedly praised the decision...

UAE: Entrepreneurs and investors can benefit from visa reforms

UAE: Entrepreneurs and investors can benefit from visa reforms

By Nikita Chaurasia

The visa and business reforms by the UAE will open new prospects for investors, entrepreneurs, IT specialists, job seekers, and tourists, according to credible sources. This will reportedly benefit the region’s economic growth. Business Link...

Flipkart introduces new tech and design upgrades ahead of holiday season

Flipkart introduces new tech and design upgrades ahead of holiday season

By Nikita Chaurasia

Flipkart, India's indigenous online marketplace, is reportedly offering customers an improved shopping experience on its widely popular app. To better serve various client groups that are exploring e-commerce during the holiday season, Flipkar...